LuciAlpe 150 mg Tablet
Prescription Required
Brand Name:
LuciAlpe
Molecule:
AlpelisibStrength:
150 mg
Quantity:
28 Tablets
Form:
Tablet
Packaging Type:
Bottle
Manufacturer/Marketed By:
Lucius PharmaCountry of Origin:
Laos
Enquiry Form
Similar Products:
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
| Alpesib 150 mg Tablet | Everest Pharma | Ask for Price |
Description
Introducing LuciAlpe (Alpelisib), a revolutionary kinase inhibitor explicitly designed for the treatment of advanced or metastatic breast cancer. Each tablet contains 150 mg of Alpelisib, expertly formulated to target PIK3CA mutations, providing a precise approach for those battling hormone receptor (HR)-positive, HER2-negative breast cancer. Indicated for postmenopausal women and men, LuciAlpe is to be used in combination with Fulvestrant. This powerful solution offers a confident step towards improved outcomes in cancer treatment for patients who have progressed on or after an endocrine-based regimen. Experience LuciAlpe's targeted efficacy and empower your journey against breast cancer. Remember that combining it with LuciAnam (Anamorelin) can enhance your therapeutic protocol.
Related Products
Lucirux Ruxolitinib 5 mg Tablet
Molecule: Ruxolitinib
Manufacturer: Lucius Pharma
Ask for Price
Enquiry Form
Related Posts:
No matching posts found.
Reviews
Clear filtersThere are no reviews yet.